Your search for comorbidities returned 6 results

Although current guidelines recommend delaying noncardiac surgery for 6 to 12 months after drug-eluting stent implantation, new data suggest surgery may be performed earlier.

Drug-eluting stents in percutaneous coronary intervention appear to be safer in patients with end-stage renal disease compared with bare-metal stents.

This simple scoring system stratified risk at 30 days and 1 year into low-risk, moderate-risk, and high-risk categories.

Aortic valve gradient was independently associated with 1-year mortality and recurrent heart failure, after adjustment, in patients undergoing transcatheter aortic valve replacement.

Obese patients were at increased risk of death compared with patients of normal weight.

The use of embolic protection during TAVR was associated with a lower total lesion volume and fewer new ischemic lesions.